Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and scientific acclamation. There are now ...

No one has ever known so much about healthy eating and been less successful at following her own advice.

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

The world’s richest man has clashed with incoming Health and Human Services chief Robert F. Kennedy Jr. over the role weight-loss medications should play in making Americans healthier and thinner.

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Elon Musk, 53, admitted to taking Mounjaro, a drug that typically treats type-2 diabetes by lowering a person's blood sugar ...

At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...